Cardiopatías Familiares e xenética cardiovascular
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublicacións en colaboración con investigadores/as de University of Michigan–Ann Arbor (2)
2020
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
2019
-
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients
Journal of Cellular and Molecular Medicine, Vol. 23, Núm. 3, pp. 2125-2135